Characteristics | CoT (n = 70) | Direct ET (n = 75) | b |
---|---|---|---|
Age, Mean (SD), y | 71.9 (10.6) | 69.1 (13.2) | 0.152 |
Gender, n F (%) | 32 (45.7) | 38 (50.6) | 0.49a |
Baseline NIHSS, median (IQR) | 18 (15–21) | 19 (15–20) | 0.55c |
Risk factors | |||
Hypertension, n (%) | 52 (74.3) | 53 (70.6) | 0.62a |
Diabetes mellitus, n (%) | 12 (17.1) | 11 (14.6) | 0.68a |
Atrial fibrillation, n (%) | 30 (42.8) | 37 (49.3) | 0.43a |
Hyperlipidemia, n (%) | 29 (41.4) | 23 (30.6) | 0.17a |
Antiplatelet or anticoagulant use, n (%) | 34 (48.6) | 37 (49.3) | 0.85a |
Sistolic Blood Pressure, Mean (SD), mmHg | 145.6 (12.6) | 147.3 (24.8) | 0.70b |
Diastolic Blood Pressure, Mean (SD), mmHg | 81.9 (15.3) | 81.1 (12.5) | 0.77b |
Serum glucose, Mean (SD), mg/dl | 130.4 (54.6) | 139.4 (82.7) | 0.59b |
ASPECTS score; median (IQR) | 9 (8–10) | 9 (8–10) | 0.06c |
Cause of stroke (TOAST) | 0.7 | ||
Large-artery disease, (%) | 23.4 | 20.0 | |
Small-artery disease, (%) | 0.0 | 0.0 | |
Cardioembolic, (%) | 54.7 | 55.0 | |
Other, (%) | 4.7 | 6.6 | |
Unknown, (%) | 17.2 | 18.4 | |
Site of occlusion | |||
tICA, n (%) | 9 (12.8) | 22 (29.3) | 0.06a |
MCA-M1 segment, n (%) | 46 (65.7) | 40 (53.3) | |
MCA-M2 segment, n (%) | 15 (21.4) | 13 (17.3) |